These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 12471601

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Identification of small-molecule inhibitors of human angiogenin and characterization of their binding interactions guided by computational docking.
    Jenkins JL, Shapiro R.
    Biochemistry; 2003 Jun 10; 42(22):6674-87. PubMed ID: 12779322
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Enhanced HTS hit selection via a local hit rate analysis.
    Posner BA, Xi H, Mills JE.
    J Chem Inf Model; 2009 Oct 10; 49(10):2202-10. PubMed ID: 19795815
    [Abstract] [Full Text] [Related]

  • 5. Consensus scoring criteria for improving enrichment in virtual screening.
    Yang JM, Chen YF, Shen TW, Kristal BS, Hsu DF.
    J Chem Inf Model; 2005 Oct 10; 45(4):1134-46. PubMed ID: 16045308
    [Abstract] [Full Text] [Related]

  • 6. Medicinal chemistry tools: making sense of HTS data.
    Kolossov E, Lemon A.
    Eur J Med Chem; 2006 Feb 10; 41(2):166-75. PubMed ID: 16368163
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Analysis of a high-throughput screening data set using potency-scaled molecular similarity algorithms.
    Vogt I, Bajorath J.
    J Chem Inf Model; 2007 Feb 10; 47(2):367-75. PubMed ID: 17300172
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Rethinking molecular similarity: comparing compounds on the basis of biological activity.
    Petrone PM, Simms B, Nigsch F, Lounkine E, Kutchukian P, Cornett A, Deng Z, Davies JW, Jenkins JL, Glick M.
    ACS Chem Biol; 2012 Aug 17; 7(8):1399-409. PubMed ID: 22594495
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Analysis of structure-based virtual screening studies and characterization of identified active compounds.
    Ripphausen P, Stumpfe D, Bajorath J.
    Future Med Chem; 2012 Apr 17; 4(5):603-13. PubMed ID: 22458680
    [Abstract] [Full Text] [Related]

  • 14. Virtual screening to enrich a compound collection with CDK2 inhibitors using docking, scoring, and composite scoring models.
    Cotesta S, Giordanetto F, Trosset JY, Crivori P, Kroemer RT, Stouten PF, Vulpetti A.
    Proteins; 2005 Sep 01; 60(4):629-43. PubMed ID: 16028223
    [Abstract] [Full Text] [Related]

  • 15. Plate-based diversity selection based on empirical HTS data to enhance the number of hits and their chemical diversity.
    Sukuru SC, Jenkins JL, Beckwith RE, Scheiber J, Bender A, Mikhailov D, Davies JW, Glick M.
    J Biomol Screen; 2009 Jul 01; 14(6):690-9. PubMed ID: 19531667
    [Abstract] [Full Text] [Related]

  • 16. Enrichment of virtual hits by progressive shape-matching and docking.
    Choi J, He N, Kim N, Yoon S.
    J Mol Graph Model; 2012 Feb 01; 32():82-8. PubMed ID: 22088763
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of binary QSAR models derived from LUDI and MOE scoring functions for structure based virtual screening.
    Prathipati P, Saxena AK.
    J Chem Inf Model; 2006 Feb 01; 46(1):39-51. PubMed ID: 16426038
    [Abstract] [Full Text] [Related]

  • 18. Identification of potent virtual leads to design novel indoleamine 2,3-dioxygenase inhibitors: pharmacophore modeling and molecular docking studies.
    John S, Thangapandian S, Sakkiah S, Lee KW.
    Eur J Med Chem; 2010 Sep 01; 45(9):4004-12. PubMed ID: 20580138
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.